Sabra Health Care REIT Hits New 52-Week High of $22.10

Sabra Health Care REIT, Inc. has reached a significant milestone by hitting a new 52-week high of USD 22.10 on July 21, 2026. This achievement underscores the company's strong performance in the realty sector, particularly within the small-cap market, where it boasts a market capitalization of approximately USD 4.95 billion. Over the past year, Sabra Health Care REIT has demonstrated impressive growth, with a performance increase of 56.65%, significantly outpacing the S&P 500's 19.09% gain during the same period. The company's price-to-earnings (P/E) ratio stands at 30.00, reflecting its valuation in the current market environment. Additionally, Sabra Health Care REIT offers a remarkable dividend yield of 561.14%, which is noteworthy for income-focused investors. With a price-to-book ratio of 1.75 and a return on equity of 5.87%, the company continues to establish its position in the realty industry. The stock's previous 52-week low was recorded at USD 17.17, highlighting the significant upward movement in its price.